Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Evotec
Biotech
Topas says celiac candidate shines but keeps data under wraps
Topas reported positive phase 2a data on its celiac disease candidate without sharing numbers to validate its upbeat outlook.
Nick Paul Taylor
Oct 15, 2024 8:08am
Evotec eyes 400 layoffs, citing 'challenging market'
Aug 14, 2024 7:48am
Evotec makes 'strategic exit' from gene therapy space
May 22, 2024 9:22am
Scorpion taps new CEO, CMO—Chutes & Ladders
Jan 5, 2024 9:30am
Evotec mitigates earnings expectations after April cyberattack
Jul 27, 2023 3:29pm
BMS pays $95M to exercise Evotec, Prothena neuroscience options
Jul 11, 2023 5:30am